553 related articles for article (PubMed ID: 31173190)
21. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
[TBL] [Abstract][Full Text] [Related]
22. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
23. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
Chen B; Sun D; Qin X; Gao XH
Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
[TBL] [Abstract][Full Text] [Related]
24. Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
Lin J; Chen Z; Li Z; Nong D; Li X; Huang G; Hao N; Liang J; Li W
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296309
[TBL] [Abstract][Full Text] [Related]
25. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
Dai H; Guo L; Lin M; Cheng Z; Li J; Tang J; Huan X; Huang Y; Xu K
PeerJ; 2020; 8():e10265. PubMed ID: 33240619
[TBL] [Abstract][Full Text] [Related]
27. Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis.
Wu K; Yi Y; Liu F; Wu W; Chen Y; Zhang W
Oncol Lett; 2018 Jul; 16(1):1003-1009. PubMed ID: 29963176
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
Zhang L; Makamure J; Zhao D; Liu Y; Guo X; Zheng C; Liang B
Exp Ther Med; 2020 Jul; 20(1):427-435. PubMed ID: 32537007
[TBL] [Abstract][Full Text] [Related]
29. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
30. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
[TBL] [Abstract][Full Text] [Related]
31. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
32. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
[TBL] [Abstract][Full Text] [Related]
33. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
34. Tetraspanin family identified as the central genes detected in gastric cancer using bioinformatics analysis.
Qi W; Sun L; Liu N; Zhao S; Lv J; Qiu W
Mol Med Rep; 2018 Oct; 18(4):3599-3610. PubMed ID: 30106120
[TBL] [Abstract][Full Text] [Related]
35. Identification of Keratinocyte Differentiation-Involved Genes for Metastatic Melanoma by Gene Expression Profiles.
Li K; Guo S; Tong S; Sun Q; Jin S; Qi B; Shao Y; Xu N
Comput Math Methods Med; 2021; 2021():9652768. PubMed ID: 35003328
[TBL] [Abstract][Full Text] [Related]
36. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
37. Identification of differentially expressed genes and biological pathways in bladder cancer.
Tang F; He Z; Lei H; Chen Y; Lu Z; Zeng G; Wang H
Mol Med Rep; 2018 May; 17(5):6425-6434. PubMed ID: 29532898
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics analysis identifies hub genes and pathways in nasopharyngeal carcinoma.
Liu K; Kang M; Zhou Z; Qin W; Wang R
Oncol Lett; 2019 Oct; 18(4):3637-3645. PubMed ID: 31516577
[TBL] [Abstract][Full Text] [Related]
39. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms.
Guo T; Hou D; Yu D
Mol Med Rep; 2019 Nov; 20(5):4415-4424. PubMed ID: 31545495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]